Carregant...
Recent changes of invasive meningococcal disease in France: arguments to revise the vaccination strategy in view of those of other countries
In France, the incidence of invasive meningococcal disease (IMD) is around 1/100,000, with the following trends over the 2011–2018 period: a leading role of group B in subjects <15 years, a decrease of group C among <1 year since 2017, an increase of group W in all age groups including subject...
Guardat en:
| Publicat a: | Hum Vaccin Immunother |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7644201/ https://ncbi.nlm.nih.gov/pubmed/32209010 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2020.1729030 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|